Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to ONO-4538 in Patients With Rhabdoid Tumor
Sponsor: Ono Pharmaceutical Co. Ltd
Summary
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Official title: A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor
Key Details
Gender
All
Age Range
1 Year - Any
Study Type
INTERVENTIONAL
Enrollment
23
Start Date
2024-11-25
Completion Date
2030-03-31
Last Updated
2026-03-12
Healthy Volunteers
No
Conditions
Interventions
ONO-4538
every 2 weeks
Locations (5)
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Hyogo Prefectural Kobe Children's Hospital
Kobe, Hyōgo, Japan
Osaka City General Hospital
Osaka, Osaka, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan